Perspectiva general
Faithful to DIA’s mission of building bridges between stakeholders to co-create tangible solutions to the challenges surrounding the development of medicinal products, we invite you to join the 2025 DIA Middle East & Africa Conference.
The objective of the meeting is to create a safe and welcoming environment where all stakeholders feel free to share hurdles, debate the best way forward, and co-create solutions. From health authorities to industry leaders, academics, and patient representatives, the strength of this meeting lies in bringing together a wide representation of those involved in the medicines development lifecycle. Key topics include regional regulatory developments, reliance, digitalisation, pharmacovigilance, and innovation.
Why you should attend:
- Collaborate with Health Authorities’ representatives and key Industry leaders from the various countries in the MEA region and contribute to shaping the future of the regulatory landscape in the region.
- Connect with 300+ participants, representing all countries in the Middle East and Africa regions and beyond.
- Discuss new strategies and processes to be implemented in the region.
- Learn how reliance, harmonisation initiatives and collaboration contribute to an efficient and sustainable regulatory system in the region.
Who will you meet?
- Regulatory Authorities’ representatives from the region.
- Experts from international organisations.
- Thought leaders, global and local stakeholders from both local and global organisations.
Featured
Want to learn more about Middle East & Africa Conference (MEA)? You've come to the right site!
Comité del programa
-
Alia Abdalla Regulatory Affairs - Senior Associate
Pfizer, Egypt -
Amira Deia Younes Director, Eastern Europe, Middle East & Africa (EEMEA) Global Regulatory Policy
MSD, United Arab Emirates -
Asma Messai
Roche Tunisie, Tunisia -
Dalia Fouad Middle East Region Head - Global Regulatory Affairs
Sanofi Aventis, United Arab Emirates -
Deema Al Naji Interim Head of Regulatory African Cluster
AstraZeneca, Jordan -
Dina Fathy, MPharm, AHIP Senior Director, Regulatory Affairs Middle East Subregional Lead
MSD UAE, United Arab Emirates -
Imane Hattami Therapeutic Area Head and Regulatory Policy Intelligence MEAR
Abbvie Biopharmaceuticals Gmbh, Morocco -
Inas Chehimi Head Regulatory Affairs - Middle East & North Africa
Novartis Pharma Services AG, United Arab Emirates
¿Tiene una cuenta?